US$ 23.36
who manufactures retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide - Wikipedia
Description
Of note, the beneficial kidney effects of canagliflozin, dapagliflozin and empagliflozin were also evident for hard kidney outcomes including chronic dialysis and kidney transplantation [252]
The sum of evidence suggests that, when detected, the use of GLP-1/GIP agonists is associated with the development of mild DR or a slight worsening of existing retinopathy
Am J Physiol Endocrinol Metab 2007

Accessed July 24, 2020 Very-low-carbohydrate ketogenic diet v
